Shirley Wen

Founder/CEO

● 10+ years of interdisciplinary product and managing experience, transforming traditional businesses with frontier digital technologies

● Ex hegdefund portfolio manager, focused on healthcare, TMT, and consumer

● MSc Accounting & Finance, The London School of Economics

Douglas McCloskey, Ph.D.

Co-founder/Chief Scientist

● Systems biologist experienced in developing automated Big Omics Data generation and analysis workflows

● Group leader, Center for Biosustainability (CfB) at the Technical University of Denmark (DTU)

● Ph.D., Bioengineering, University of California, San Diego in the Bernhard Ø. Palsson lab

● Recipient of the Siebel Scholar – awarded annually for academic excellence and demonstrated leadership to 93 top students from the world‘s leading graduate schools

● Publication H-index of 21

Dimitris Christodoulou, Ph.D.

Co-founder/Chief Strategy Officer

● Strategist & computational biologist with experience in data analytics, multi-omics integration & simulation

● Ex-Senior Consultant at Deloitte Consulting (Zurich), led the design and implementation of business and technology strategies as well as data solutions for global MNCs

● Visiting Scholar in Systems Biology, Harvard Medical School

● Ph.D. & Post-Doc, Computational Biology, ETH Zurich

● Published multiple top tier publications (i.e. Nature, Cell Systems, iScience)

Xiaoqiang Hou, Ph.D.

Co-founder/Chief Operating Officer

● Deputy Secretary-General of Internet Hospital Association

● 20 years experience in research management, and clinical hospital management

● Research background in tumor and rare diseases, pathogenic mechanisms and vaccines

● Presided over a number of National Key Research Projects

● Ph.D. in Virology, Jilin University

Haihong Liu, M.D.

Technical Director of Clinical Laboratory

● Ex-Medical Laboratory Specialist of General Hospital of Beijing Military Region

● Genetic Metabolic Disease Laboratory Director of Bayi Children's Hospital

● Specialized in molecular biology and immunology diagnosis

● Evaluation expert of Beijing natural science foundation

● M.D. in preventive medicine, Academy of Military Medical Sciences

Wei Ye, Ph.D.

VP Scientific Affairs

● Head of Bioinformatics Platform, Bio-Med Big Data Center, Shanghai Institute of Biological Sciences, CAS, lead efforts of building NODE (National Omics Data Encylopedia)

● 10 years experience in multi-omics bioinformatics analysis

● Director of Bioinformatics, Shanghai Tissue Bank Co. Ltd.

● Project Assistant at Roche pRED China

● Ph.D. in Biology, Shanghai Jiaotong University

Atefeh Kazeroonian, Ph.D.

Computational Modelling Director

● Computational biologist, experienced in mechanistic modelling and omics data integration with a focus on the immune system

● Group leader in computational biology and T cell immunology, Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich

● Ph.D., Computational Biology, Helmholtz Center in Munich in the Fabian Theis lab

● Visiting scholar, University of California, San Francisco

● Published multiple top tier publications (i.e. Nature Immunology, PNAS, Bioinformatics)

Robin Chan, Ph.D.

VP of Strategic Partnerships

● 10+ years of experience in research and life science industry

● Founding director of Lipidomics Core Laboratory, Columbia University

● Assistant Professor of Pathology and Cell Biology, Lipid Metabolism and Neurodegenerative Diseases, Columbia University

● U.C. Berkeley Skydeck BioChina Fund partner

● PhD, Biochemistry, National University of Singapore, in the Lab of Markus R. Wenk; MBA, Columbia Business School

● Published 35+ top-tier publications (i.e. Nature, Nat Commun., Nat Neurosci., Cell Host Microbe), received research grants from National Institute of Health (NIH) and other non-profit research foundations 

Chunjian Huang, Ph.D.

VP of Immunology

● 20+ years international experience in immunology-focused research institutes and biotechnology companies (e.g. cancer immunotherapy, autoimmunity, asthma and inflammation)

● Served as Director at Department of Oncology and Immunology, WuXi AppTec. Led R&D progress that enabled the development of new modalities and was involved in multiple successful IND applications

● Served as Principal Investigator at Innovent Biologics. Led team for first-in-class drug target discovery and successfully completed the POC of one FIC target within one year

● PostDoc, Cleveland Clinic (Department of Cancer Biology); Ph.D. in Immunology, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences; B.Sc. in Biology, Fudan University 

Wei Ye, Ph.D.

Co-founder/SVP of Technology Operations

● 10+ years experience in bioinformatics research institutes and pharmaceutical companies (focus on NGS, multi-omics data analysis, CADD)

● Served as Director of the Bioinformatics Platform, Shanghai Academy of Biological Sciences, Chinese Academy of Sciences. Led multiple national omics database setup and data analysis programs

● Served at the Roche R&D Center Bioinformatics and worked on several drug discovery projects

● Ph.D. in Biology (Bioinformatics), Shanghai Jiaotong University

● Published 20+ SCI papers, including 8 first-authored papers, with 500+ citations